Peer Review History

Original SubmissionJune 14, 2024
Decision Letter - Diego Moriconi, Editor

PONE-D-24-24065Adjusting dialysis dose (Kt) scaled to Body Surface Area (BSA) could be a more logical approachPLOS ONE 

Dear Dr. ma,

thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. 

Please submit your revised manuscript by Oct 06 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Diego Moriconi

Academic Editor

PLOS ONE

Journal requirements:   

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In the online submission form, you indicated that [The datasets used and/or analyzed during the present study are available from the corresponding author on reasonable request.]. 

All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval. 

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Dear Dr. Chunyuan Ma,

we have received the reports from our advisors on your manuscript, "Adjusting dialysis dose (Kt) scaled to Body Surface Area (BSA) could be a more logical approach", submitted to our journal Plos One.

Based on the advice received, I have decided that your manuscript could be reconsidered for publication should you be prepared to incorporate minor revisions.

When preparing your revised manuscript, you are asked to carefully consider the reviewer comments which can be found below, and submit a list of responses to the comments.

Best regards,

Dr. Diego Moriconi, MD, PhD.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

********** 

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

********** 

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript presents an interesting approach to scaling dialysis dose (Kt) to body surface area (BSA) instead of the conventional urea distribution volume (V) for a more accurate reflection of metabolic activity. The study is well-structured, with a clear abstract and comprehensive results.

The manuscript states that linear regression analysis was applied, but it does not provide details about the regression model assumptions, the goodness-of-fit metrics, or the potential multicollinearity issues. Including information about the model diagnostics (residual analysis, R-squared values) and any steps taken to validate the regression model would strengthen the analysis.

Reviewer #2: In this single-centre cross-sectional study, the researchers investigated the efficacy of hemodialysis, as measured by Kt/V versus Kt/BSA, in 211 patients with end-stage chronic kidney disease undergoing chronic hemodialysis. The focus of the two dialysis parameters for adequacy was on gender comparison. The inclusion and exclusion criteria are clear. The study was approved by the ethics committee and all participants signed a written informed consent. Most of the participants had an arteriovenous fistula as vascular access. The researchers found significantly higher Kt/V values in women than in men and after normalisation from Kt to BSA, the difference between the two sexes was no longer statistically significant.

The manuscript is well written, the entire text needs to be reviewed by a native English speaker.

I have the following comments, questions, suggestions:

1. When were the blood samples for the Kt/V measurements taken? At the first, second or third hemodialysis session of the week?

2. Do all patients have the same weekly schedule for dialysis sessions?

3. Data on the duration of the hemodialysis session of the participants at the time of blood sampling is missing.

4. Data on the type of dialysis (hemodialysis, hemofiltration, hemodiafiltration) are missing.

5. Minor comments:

Table 1: SBA is incorrect, it is BSA

Relationship between Kt/V and Kt/BSA by gender (not by sex)

********** 

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Response to reviewers

Dear editor and reviewers of PLoS One:

Our reference: PONE-D-24-24065

Title: Adjusting dialysis dose (Kt) scaled to Body Surface Area (BSA) could be a more logical approach

By: Liu Wei et al

Thank you very much for your letter and for the editors’ and reviewers’ comments concerning our manuscript entitled “Adjusting dialysis dose (Kt) scaled to Body Surface Area (BSA) could be a more logical approach” (ID: PONE-D-24-24065). These comments are of great reference value to the revision and improvement of our paper and have important guiding significance to our researches. The main corrections in the paper and the responds to the reviewer’s comments are as flowing:

Reviewer #1: The manuscript presents an interesting approach to scaling dialysis dose (Kt) to body surface area (BSA) instead of the conventional urea distribution volume (V) for a more accurate reflection of metabolic activity. The study is well-structured, with a clear abstract and comprehensive results.

The manuscript states that linear regression analysis was applied, but it does not provide details about the regression model assumptions, the goodness-of-fit metrics, or the potential multicollinearity issues. Including information about the model diagnostics (residual analysis, R-squared values) and any steps taken to validate the regression model would strengthen the analysis.

Author's reply:The article adds the corresponding content as follows:

“Femle,Kt/V and Kt/BSA regression equation:Kt/BSA(f)=0.34+0.73×Kt/V(f)(Analysis of variance on the model result:F=107.59,P<0.01; r=0.77,R2=0.60,Std. Error of the Estimate is 0.11,Durbin-Watson Statistic is 2.15);Male,Kt/V and Kt/BSA regression equation:Kt/BSA(m)=0.30+0.87×Kt/V(m)(Analysis of variance on the model result:F=384.70,P<0.01; r=0.86,R2=0.74,Std. Error of the Estimate is 0.14,Durbin-Watson Statistic is 1.93)”

and

”Femle,BSA and V regression equation:V(f)=-5.01+21.92×BSA(f)(Analysis of variance on the model result:F=90.58 ,P<0.01 ; r=0.74,R2=0.55,Std. Error of the Estimate is 2.24 ,Durbin-Watson Statistic is 2.19) ;Male,BSA and V regression equation:V(m)=-22.29+34.91×BSA(m) (Analysis of variance on the model result:F=418.19 ,P<0.01 ; r=0.87,R2=0.76,Std. Error of the Estimate is 3.29,Durbin-Watson Statistic is 1.95).”

Reviewer #2: In this single-centre cross-sectional study, the researchers investigated the efficacy of hemodialysis, as measured by Kt/V versus Kt/BSA, in 211 patients with end-stage chronic kidney disease undergoing chronic hemodialysis. The focus of the two dialysis parameters for adequacy was on gender comparison. The inclusion and exclusion criteria are clear. The study was approved by the ethics committee and all participants signed a written informed consent. Most of the participants had an arteriovenous fistula as vascular access. The researchers found significantly higher Kt/V values in women than in men and after normalisation from Kt to BSA, the difference between the two sexes was no longer statistically significant.

The manuscript is well written, the entire text needs to be reviewed by a native English speaker.

I have the following comments, questions, suggestions:

1.When were the blood samples for the Kt/V measurements taken? At the first, second or third hemodialysis session of the week?

Author's reply:In the article, Kt/V represents the dose for a single treatment,The blood samples were taken randomly.The measurement time is not fixed.

2.Do all patients have the same weekly schedule for dialysis sessions?

Author's reply:Yes,the hemodialysis regimen mandates a thrice-weekly session schedule, with each session lasting four hours.

The article added "Hemodialysis Treatment Protocol" related content as follows:

3.“3.Hemodialysis Treatment Protocol: Hemodialysis is performed a thrice-weekly session schedule, with each session lasting four hours. Blood flow rate is set between 200-300 mL/min, and dialysate flow is 500 mL/min. A standardized, glucose-free, bicarbonate-based dialysate is used for hemodialysis procedures. Anticoagulation with calcium-based heparin prevents clots, The use of single-use dialyzers and dialysis tubing is mandatory to uphold the highest standards of patient safety.”

3.Data on the duration of the hemodialysis session of the participants at the time of blood sampling is missing.

Author's reply:The article adds the corresponding content as follows: please see table 1

4.Data on the type of dialysis (hemodialysis, hemofiltration, hemodiafiltration) are missing.

Author's reply:We only have two types of dialysis(hemodialysis(HD) and hemodiafiltration(HDF)).The article adds the corresponding content as follows: please see table 2

5. Minor comments:

Table 1: SBA is incorrect, it is BSA

Relationship between Kt/V and Kt/BSA by gender (not by sex)

Author's reply:The corresponding part of the article has been revised.

Once again, thank you very much for your comments and suggestions.

2024-08-30

Attachments
Attachment
Submitted filename: Response to reviewers R1.docx
Decision Letter - Diego Moriconi, Editor

Adjusting dialysis dose (Kt) scaled to Body Surface Area (BSA) could be a more logical approach

PONE-D-24-24065R1

Dear Dr. Chunyuan Ma,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Diego Moriconi

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Dear Dr. Chunyuan Ma,

we have received the report from our advisor on your manuscript, "Adjusting dialysis dose (Kt) scaled to Body Surface Area (BSA) could be a more logical approach", submitted to our journal Plos One.

Based on the advice received, the paper is considered, in light of the improvements made, suitable for publication.

Best regards,

Dr. Diego Moriconi, MD, PhD.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: The authors took into account all my suggestions and comments and I think that the paper has been improved. Thank you.

I think the article is now suitable for publication.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Diego Moriconi, Editor

PONE-D-24-24065R1

PLOS ONE

Dear Dr. Ma,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Diego Moriconi

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .